RegentAtlantic Capital’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $699K | Sell |
3,340
-389
| -10% | -$81.4K | 0.02% | 378 |
|
2022
Q2 | $879K | Sell |
3,729
-395
| -10% | -$93.1K | 0.03% | 338 |
|
2022
Q1 | $740K | Sell |
4,124
-288
| -7% | -$51.7K | 0.02% | 373 |
|
2021
Q4 | $953K | Sell |
4,412
-137
| -3% | -$29.6K | 0.03% | 331 |
|
2021
Q3 | $840K | Sell |
4,549
-983
| -18% | -$182K | 0.03% | 332 |
|
2021
Q2 | $992K | Sell |
5,532
-1,354
| -20% | -$243K | 0.03% | 295 |
|
2021
Q1 | $1.15M | Sell |
6,886
-641
| -9% | -$107K | 0.04% | 259 |
|
2020
Q4 | $1.14M | Buy |
7,527
+1,411
| +23% | +$214K | 0.05% | 228 |
|
2020
Q3 | $618K | Buy |
6,116
+2,962
| +94% | +$299K | 0.03% | 294 |
|
2020
Q2 | $382K | Buy |
+3,154
| New | +$382K | 0.02% | 342 |
|
2019
Q3 | – | Sell |
-3,378
| Closed | -$264K | – | 458 |
|
2019
Q2 | $264K | Sell |
3,378
-1,715
| -34% | -$134K | 0.02% | 378 |
|
2019
Q1 | $598K | Sell |
5,093
-50
| -1% | -$5.87K | 0.04% | 271 |
|
2018
Q4 | $560K | Sell |
5,143
-526
| -9% | -$57.3K | 0.05% | 268 |
|
2018
Q3 | $725K | Sell |
5,669
-498
| -8% | -$63.7K | 0.06% | 255 |
|
2018
Q2 | $698K | Sell |
6,167
-2,265
| -27% | -$256K | 0.06% | 249 |
|
2018
Q1 | $947K | Sell |
8,432
-3,777
| -31% | -$424K | 0.08% | 217 |
|
2017
Q4 | $1.81M | Sell |
12,209
-714
| -6% | -$106K | 0.15% | 157 |
|
2017
Q3 | $1.51M | Buy |
12,923
+315
| +2% | +$36.9K | 0.13% | 168 |
|
2017
Q2 | $1.64M | Sell |
12,608
-1,795
| -12% | -$233K | 0.15% | 153 |
|
2017
Q1 | $1.95M | Sell |
14,403
-1,130
| -7% | -$153K | 0.18% | 141 |
|
2016
Q4 | $2.23M | Buy |
15,533
+2,785
| +22% | +$399K | 0.22% | 124 |
|
2016
Q3 | $1.51M | Sell |
12,748
-815
| -6% | -$96.2K | 0.16% | 150 |
|
2016
Q2 | $1.44M | Buy |
13,563
+1,285
| +10% | +$136K | 0.14% | 148 |
|
2016
Q1 | $1.37M | Buy |
+12,278
| New | +$1.37M | 0.15% | 140 |
|
2015
Q1 | – | Sell |
-313
| Closed | -$40.5K | – | 917 |
|
2014
Q4 | $40.5K | Buy |
+313
| New | +$40.5K | ﹤0.01% | 628 |
|